Parker Geoffrey M.

Track record

How each disclosed position did against the S&P ~6 months later

The outcome curve and every position's resultPro →

-37.8%

median move per position

+7.9%

S&P 500 median, same spans

0 of 1

beat the S&P ~6mo later

Disclosed positions

Estimated from their latest filings — positions may have changed since

Estimated positions from their latest filingsPro →

Activity

Open-market buy & sell volume

BuySell

Total +$206.8K bought · −$88.4K sold

All filings on record

Every Form 4 transaction we track for this filer

All6Buys2Sells2

Stock	Transaction	Date	~6mo vs S&P
PRGOPERRIGO Co plc	Tax $8.3K · 607 sh	2026-09-11	—
PRGOPERRIGO Co plc	Exercise $17.3K · 1,263 sh	2026-09-11	—
ALLOAllogene Therapeutics, Inc.	Sell $42.2K · 24,001 sh	2026-02-02	—
PRGOPERRIGO Co plc	Buy $106.3K · 7,500 sh	2025-11-12	—
ALLOAllogene Therapeutics, Inc.	Sell $46.2K · 36,744 sh	2025-10-21	—
PRGOPERRIGO Co plc	Buy $100.5K · 4,375 sh	2025-08-18	—

PRGOTax

2026-09-11 · PERRIGO Co plc

$8.3K

—

PRGOExercise

2026-09-11 · PERRIGO Co plc

$17.3K

—

ALLOSell

2026-02-02 · Allogene Therapeutics, Inc.

$42.2K

—

PRGOBuy

2025-11-12 · PERRIGO Co plc

$106.3K

—

ALLOSell

2025-10-21 · Allogene Therapeutics, Inc.

$46.2K

—

PRGOBuy

2025-08-18 · PERRIGO Co plc

$100.5K

—

6 filings·Every Form 4 on record, with outcomesPro →

Filing in the same companies

Other insiders active in these names in the last 3 years

AB

Alford Bradley A

PRGO · last 2026-09-11

BD

Ball David

PRGO · last 2026-09-09

DE

Douglas Earl Martin

ALLO · last 2026-08-21

KR

Khoury Roberto

PRGO · last 2026-07-08

WM

Winterman Matthew John

PRGO · last 2026-07-08

KJ

Kazam Joshua A

ALLO · last 2026-06-18

Outcomes measure each position — the first buy in a stock and every buy within 182 days — against the closing price ~6 months (120 trading days) later, with the S&P 500 over the same span for context. Pre-scheduled 10b5-1 plan trades are excluded from the record. Positions are estimated from the latest reported post-transaction holdings, split-adjusted, at the latest close. Built from SEC Form 4 filings and market prices — past outcomes, not predictions or advice.